WordNet

develop into a distinctive entity; "our plans began to take shape" (同)take form, take shape, spring
assume a form or shape; "the water formed little beads"
the visual appearance of something or someone; "the delicate cast of his features" (同)shape, cast
a mold for setting concrete; "they built elaborate forms for pouring the foundation"
a particular mode in which something is manifested; "his resentment took the form of extreme hostility"
a perceptual structure; "the composition presents problems for students of musical form"; "a visual pattern must include not only objects but the spaces between them" (同)shape, pattern
(biology) a group of organisms within a species that differ in trivial ways from similar groups; "a new strain of microorganisms" (同)variant, strain, var.
the phonological or orthographic sound or appearance of a word that can be used to describe or identify something; "the inflected forms of a word can be represented by a stem and a list of inflections to be attached" (同)word form, signifier, descriptor
a printed document with spaces in which to write; "he filled out his tax form"
an ability to perform well; "he was at the top of his form"; "the team was off form last night"
an arrangement of the elements in a composition or discourse; "the essay was in the form of a dialogue"; "he first sketches the plot in outline form"
to compose or represent:"This wall forms the background of the stage setting"; "The branches made a roof"; "This makes a fine introduction" (同)constitute, make
create (as an entity); "social groups form everywhere"; "They formed a company" (同)organize, organise
an amino acid that does not occur in proteins but is found in the muscle tissue of vertebrates both in the free form and as phosphocreatine; supplies energy for muscle contraction (同)creatin
the 13th letter of the Roman alphabet (同)m
an enzyme that catalyzes the conversion of a proenzyme to an active enzyme

PrepTutorEJDIC

〈C〉〈U〉(色・材質に対して)『形』,形状,姿 / 〈C〉『人体』,体つき / 〈C〉〈U〉『外観』,格好,人影 / 〈C〉〈U〉(ものの現れる)『形態』,形式 / 〈C〉(生物などの)『種類』,品種 / 〈U〉(芸術作品の)表現形式 / 〈U〉(特にスポーツで)(競技者の)フォーム / 〈U〉(心身の)調子,元気 / 〈C〉(印刷された)書き込み用紙,ひな形 / 〈U〉《話》(ある集団などの)やり方,仕方,方式 / 〈C〉〈U〉しきたり,伝統的な儀式 / 〈C〉(英国の学校・米国のある学校で)学年,学級 / 〈U〉〈C〉(意味に対する)形態,形;語形 / 〈C〉(通例寄りかかりのない)長い木のいす / 〈素材〉‘に'形を与える,(…に)…‘を'形作る《+『名』+『into』+『名』》 / (素材から)…‘を'形作る《+『名』+『out of』+『名』》 / …‘を'組織する,構成する / 〈考えなど〉‘を'まとめる,思い付く;〈計画など〉‘を'立てる / 〈習慣など〉‘を'身に付ける;〈交際など〉‘を'結ぶ / 〈文章など〉‘を'組み立てる;〈複数形など〉‘を'作る / (ある順序に)配列する,整列させる / 〈物が〉形を成す / 生じる,現れる / (…に)なる《+『into』+『名』》
《時間・距離》『…の間』 / 《利益・貢献》『…のために』 / 《適応・用途》『…向きの(に);』…用の(に);…のための(に) / 《目的・意向》『…のために,』に / 《敬意・記念》『…のために;』…を記念して / 《獲得・追求》『…を得るために』,を求めて / 《行く先・方向》『…あてに;』…[方面]行きの,に向けて / 《交換・報償など》『…に対して』;…と引き換えに;…のお返しに / 《原因・理由》『…のために』,なので / 《代理・代表》『…の代わりに;』…を代表して / 《形容詞の後に用いて》『…にとって,』には / 《比較級の後に用いて》『…の結果として,』…のために / 《対比》『…としては,』のわりには / 《関連》『…について,』の点では / 《資格・属性》『…として』 / 《賛成・支持》…『に賛成して』,を支持して / 《傾向・好み》…『に対する』,には / 《模倣》《おもに米》《英文》…の名を取って(after) / 《割合》…に対して / 《『for』+『名』〈人〉+『to』 doの形で,〈人〉が不定詞to doの意味上の主語を表して》…が(…することは,…するために) / […というのは]…だから
Mach number / mark[s] / Monsieur

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 神経筋疾患の評価における筋酵素 muscle enzymes in the evaluation of neuromuscular diseases
2. Troponins as biomarkers of cardiac injury
3. ヘム色素誘発急性腎障害（急性腎不全）の臨床的特徴および診断 clinical features and diagnosis of heme pigment induced acute kidney injury acute renal failure
4. 好酸球性筋膜炎 eosinophilic fasciitis
5. 筋萎縮性側索硬化症およびその他の運動ニューロン疾患の診断 diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease

English Journal

Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption.

Demonbreun AR1, Allen MV2, Warner JL2, Barefield DY2, Krishnan S3, Swanson KE4, Earley JU2, McNally EM2.
The American journal of pathology.Am J Pathol.2016 Jun;186(6):1610-22. doi: 10.1016/j.ajpath.2016.02.005. Epub 2016 Apr 9.
Dysferlin is a membrane-associated protein implicated in membrane resealing; loss of dysferlin leads to muscular dystrophy. We examined the same loss-of-function Dysf mutation in two different mouse strains, 129T2/SvEmsJ (Dysf(129)) and C57BL/6J (Dysf(B6)). Although there are many genetic difference
PMID 27070822

Determination of the anti-inflammatory and cytoprotective effects of l-glutamine and l-alanine, or dipeptide, supplementation in rats submitted to resistance exercise.

Raizel R1, Leite JS1, Hypólito TM1, Coqueiro AY1, Newsholme P2, Cruzat VF2, Tirapegui J1.
The British journal of nutrition.Br J Nutr.2016 May 24:1-10. [Epub ahead of print]
We evaluated the effects of chronic oral supplementation with l-glutamine and l-alanine in their free form or as the dipeptide l-alanyl-l-glutamine (DIP) on muscle damage, inflammation and cytoprotection, in rats submitted to progressive resistance exercise (RE). Wistar rats (n 8/group) were submitt
PMID 27215379

Outcome of a glucocorticoid discontinuation regimen in patients with inactive systemic sclerosis.

Iudici M1, Vettori S1, Russo B1, Giacco V1, Capocotta D1, Valentini G2.
Clinical rheumatology.Clin Rheumatol.2016 May 17. [Epub ahead of print]
Glucocorticoids (GC) are widely used to treat systemic sclerosis (SSc). The lack of efficacy data and patient/physician concerns may prompt therapy discontinuation. The aim of this study is to identify factors hampering GC discontinuation in patients with stable disease on oral GC for longer than 12
PMID 27184047

Japanese Journal

高速液体クロマトグラフィーによるクレアチンキナーゼアイソエンザイムの活性測定への固定化酵素カラムリアクターの応用(<特集>生体成分の高速液体クロマトグラフィー)

林守正^[○!R],三上博久,石田泰夫
分析化学 33(7), 381-385, 1984-07-05
テトラエトキシシランから合成される含フッ素ゲル状化合物を固定化用担体に用い,ヘキソキナーゼ及びグルコースー6-リン酸デヒドロゲナーゼの固定化酵素カラムリアクターを作製して,高速液体クロマトグラフィーによって分離したヒト血清中クレアチソキナーゼアイソェンザイムの活性測定に応用した. クレアチンキナーゼによって生成したアデノシン三リン酸は高感度で検出され,その検出限界は15 Dmol であった. 各ア …
NAID 110002908977